Edwards Lifesciences Corp

EWNYSE • USD
90.09 USD
↗ 1.69 (1.91%)AT CLOSE (03:59 PM EDT)
89.95
↘ 0.14 (0.16%)
POST MARKET (AS OF 07:46 PM EDT)
Post Market
AS OF 07:46 PM EDT
89.95
↘ 0.14 (0.16%)
🔴Market: CLOSED

Edwards Lifesciences Corp (EW) trades at $90.75 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Oct 22, 2026.

Open?$88.64
High?$90.19
Low?$88.28
Prev. Close?$88.40
Volume?3.1M
Avg. Volume?3.6M
VWAP?$89.52
Rel. Volume?0.84x
Bid / Ask
Bid?$88.00 × 100
Ask?$91.50 × 300
Spread?$3.50
Midpoint?$89.75
Valuation & Ratios
Market Cap?51.0B
Shares Out?575.8M
Float?571.0M
Float %?99.2%
P/E Ratio?50.71
P/B Ratio?4.80
EPS?$1.74
Dividend?0.00%
Ex-Dividend?N/A
RelatedAMNHSIC
News
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Employees
16.0K
Market Cap
51.0B
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2000-04-03
Address
ONE EDWARDS WAY
IRVINE, CA 92614
Phone: (949) 250-2500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
31
Short Sent.?
64
Piotroski F-Score?3/9Weak
Altman Z-Score?12.50Safe
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.67%Low
Short Interest?9.5M
Days to Cover?2.5
Free Float571.0M
Avg Daily Volume3.9M
Settlement Date2026-09-30
Financial Health
Current Ratio?4.52Strong
Quick Ratio?3.77Strong
Cash Ratio?1.93Strong
Debt/Equity?0.06Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
39/100
P/E?
Peers
33
S&P
12
50.7PRICEY▾
P/B?
Peers
33
S&P
38
4.80FAIR▾
P/S?
Peers
33
S&P
14
7.82HIGH▾
P/FCF?
Peers
33
S&P
21
35.5PRICEY▾
EV/EBITDA?
Peers
33
S&P
16
24.6HIGH▾
EV/Sales?
Peers
33
S&P
18
7.47HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
32
9.5%FAIR▾
ROA?
Peers
100
S&P
61
7.2%STRONG▾
Cash Flow & Enterprise
FCF?$1.4B
Enterprise Value?$48.6B
Fundamentals ratios updated end of day